Most of the top genes were upregulated and/or contributed to promotion of GBM tumorigenicity, but few of them were downregulated and/or identified as protective prognostic factors, e.g., BMP4, DUSP7, GCSH, NF2, PHF5A, and RXRG. The gene discussed is NF2; the disease is glioblastoma.